These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25524438)

  • 1. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study.
    Drogan D; Dunn WB; Lin W; Buijsse B; Schulze MB; Langenberg C; Brown M; Floegel A; Dietrich S; Rolandsson O; Wedge DC; Goodacre R; Forouhi NG; Sharp SJ; Spranger J; Wareham NJ; Boeing H
    Clin Chem; 2015 Mar; 61(3):487-97. PubMed ID: 25524438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma metabolites associated with healthy Nordic dietary indexes and risk of type 2 diabetes-a nested case-control study in a Swedish population.
    Shi L; Brunius C; Johansson I; Bergdahl IA; Lindahl B; Hanhineva K; Landberg R
    Am J Clin Nutr; 2018 Sep; 108(3):564-575. PubMed ID: 30060042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma Vitamin D Metabolites With Incident Type 2 Diabetes: EPIC-InterAct Case-Cohort Study.
    Zheng JS; Imamura F; Sharp SJ; van der Schouw YT; Sluijs I; Gundersen TE; Ardanaz E; Boeing H; Bonet C; Gómez JH; Dow C; Fagherazzi G; Franks PW; Jenab M; Kühn T; Kaaks R; Key TJ; Khaw KT; Lasheras C; Mokoroa O; Mancini FR; Nilsson PM; Overvad K; Panico S; Palli D; Rolandsson O; Sieri S; Salamanca-Fernández E; Sacerdote C; Spijkerman AMW; Stepien M; Tjonneland A; Tumino R; Butterworth AS; Riboli E; Danesh J; Langenberg C; Forouhi NG; Wareham NJ
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1293-1303. PubMed ID: 30418614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.
    Jacobs S; Kröger J; Floegel A; Boeing H; Drogan D; Pischon T; Fritsche A; Prehn C; Adamski J; Isermann B; Weikert C; Schulze MB
    Am J Clin Nutr; 2014 Sep; 100(3):891-900. PubMed ID: 25057154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort.
    Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Drouin-Chartier JP; Schulze MB
    Clin Nutr; 2021 Aug; 40(8):4988-4999. PubMed ID: 34364238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
    Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
    PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metabolite biomarkers of boiled and filtered coffee intake and their association with type 2 diabetes risk.
    Shi L; Brunius C; Johansson I; Bergdahl IA; Rolandsson O; van Guelpen B; Winkvist A; Hanhineva K; Landberg R
    J Intern Med; 2020 Apr; 287(4):405-421. PubMed ID: 31814205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study.
    Yang SJ; Kwak SY; Jo G; Song TJ; Shin MJ
    Sci Rep; 2018 May; 8(1):8207. PubMed ID: 29844477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case-control study in the HUNT and Lifelines cohorts.
    Gängler S; Waldenberger M; Artati A; Adamski J; van Bolhuis JN; Sørgjerd EP; van Vliet-Ostaptchouk J; Makris KC
    Metabolomics; 2019 Apr; 15(4):60. PubMed ID: 30963292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint Analysis of Metabolite Markers of Fish Intake and Persistent Organic Pollutants in Relation to Type 2 Diabetes Risk in Swedish Adults.
    Shi L; Brunius C; Bergdahl IA; Johansson I; Rolandsson O; Donat Vargas C; Kiviranta H; Hanhineva K; Åkesson A; Landberg R
    J Nutr; 2019 Aug; 149(8):1413-1423. PubMed ID: 31209490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.
    Dietrich S; Floegel A; Troll M; Kühn T; Rathmann W; Peters A; Sookthai D; von Bergen M; Kaaks R; Adamski J; Prehn C; Boeing H; Schulze MB; Illig T; Pischon T; Knüppel S; Wang-Sattler R; Drogan D
    Int J Epidemiol; 2016 Oct; 45(5):1406-1420. PubMed ID: 27591264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population.
    Ren M; Lin DZ; Liu ZP; Sun K; Wang C; Lao GJ; Fan YQ; Wang XY; Liu J; Du J; Zhu GB; Wang JH; Yan L
    Front Endocrinol (Lausanne); 2021; 12():745214. PubMed ID: 35069433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.
    Podmore C; Meidtner K; Schulze MB; Scott RA; Ramond A; Butterworth AS; Di Angelantonio E; Danesh J; Arriola L; Barricarte A; Boeing H; Clavel-Chapelon F; Cross AJ; Dahm CC; Fagherazzi G; Franks PW; Gavrila D; Grioni S; Gunter MJ; Gusto G; Jakszyn P; Katzke V; Key TJ; Kühn T; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sánchez-Cantalejo E; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; Feskens EJ; Forouhi NG; Sharp SJ; Riboli E; Langenberg C; Wareham NJ
    Diabetes Care; 2016 Apr; 39(4):572-81. PubMed ID: 26861925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biomarkers for pre-diabetes identified by metabolomics.
    Wang-Sattler R; Yu Z; Herder C; Messias AC; Floegel A; He Y; Heim K; Campillos M; Holzapfel C; Thorand B; Grallert H; Xu T; Bader E; Huth C; Mittelstrass K; Döring A; Meisinger C; Gieger C; Prehn C; Roemisch-Margl W; Carstensen M; Xie L; Yamanaka-Okumura H; Xing G; Ceglarek U; Thiery J; Giani G; Lickert H; Lin X; Li Y; Boeing H; Joost HG; de Angelis MH; Rathmann W; Suhre K; Prokisch H; Peters A; Meitinger T; Roden M; Wichmann HE; Pischon T; Adamski J; Illig T
    Mol Syst Biol; 2012; 8():615. PubMed ID: 23010998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
    Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
    Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.